Status:
COMPLETED
Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19
Lead Sponsor:
Quovadis Associazione
Collaborating Sponsors:
Azienda Ospedaliera di Padova
Conditions:
COVID-19 Disease
Thromboembolism, Venous
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to verify if patients admitted to hospital in a medical division and in the intensive care unit for a COVID-19 infection are at higher risk of developing a VTE complication an...
Detailed Description
Between December 2019 and January 2020, a new type of coronavirus, named as "coronavirus disease 2019 - COVID-19" by the World Health Organization, has widely spread throughout the world, becoming a g...
Eligibility Criteria
Inclusion
- aged \>= 18 years
- needing admission to a medical hospital division or to an ICU
- with a confirmed infection for COVID-19
Exclusion
- aged \< 18 years
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04359212
Start Date
May 1 2020
End Date
July 31 2020
Last Update
September 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Giuseppe Camporese
Padua, Italy, 35138